Description
Class C07J : STEROIDS
Subclass 51/00: Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups C07J 1/00-C07J 43/00
C07J 51/00
Sub-Class
Stats
- 133 US PATENTS IN FORCE
- 18 US APPLICATIONS PENDING
- 54 Total Patent Owners
- 439 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 12227537 | Intermediates for the preparation of 11-methylene steroids | May 13, 21 | Feb 18, 25 | CRYSTAL PHARMA, S.A.U. |
| 12065463 | Compositions and methods for treating CNS disorders | Oct 24, 22 | Aug 20, 24 | SAGE THERAPEUTICS, INC. |
| 12011450 | Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof | Feb 21, 23 | Jun 18, 24 | Board of Regents of the University of Nebraska |
| 11958879 | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof | May 19, 21 | Apr 16, 24 | Enanta Pharmaceuticals, Inc. |
| 11939353 | Fluorinated and alkylated bile acids | Jul 16, 21 | Mar 26, 24 | Metselex, Inc. |
| 11896672 | Targeted nucleic acid conjugate compositions | Apr 11, 17 | Feb 13, 24 | ARBUTUS BIOPHARMA CORPORATION |
| 11753435 | Process | Dec 15, 21 | Sep 12, 23 | Avecho Biotechnology Limited |
| 11725025 | Progesterone phosphate analogs and uses related thereto | Jun 28, 21 | Aug 15, 23 | Emory University |
| 11718641 | Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof | Feb 26, 21 | Aug 08, 23 | Enanta Pharmaceuticals, Inc. |
| 11583541 | Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof | Mar 01, 21 | Feb 21, 23 | Board of Regents of the University of Nebraska |
| 11542298 | Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof | Mar 03, 20 | Jan 03, 23 | EPIRIUM BIO INC. |
| 11542297 | Compositions and methods for treating CNS disorders | Mar 15, 22 | Jan 03, 23 | SAGE THERAPEUTICS, INC. |
| 11530237 | Compositions and methods for treating CNS disorders | Jan 21, 20 | Dec 20, 22 | SAGE THERAPEUTICS, INC. |
| 11479577 | Intermediates for the synthesis of bile acid derivatives, in particular of obeticholic acid | Feb 26, 21 | Oct 25, 22 | NZP UK Limited |
| 11384114 | Polymorphic forms of an oxysterol and methods of making them | Dec 09, 16 | Jul 12, 22 | Warsaw Orthopedic, Inc. |
| 11324759 | Oxysterol-statin compounds for bone growth | May 21, 19 | May 10, 22 | Warsaw Orthopedic, Inc. |
| 11318206 | Compounds and methods for trans-membrane delivery of molecules | Aug 17, 16 | May 03, 22 | Aposense Ltd. |
| 11254702 | Thionyl tetrafluoride modified compounds and uses | Nov 29, 17 | Feb 22, 22 | The Scripps Research Institute |
| 11147877 | Compositions and methods for treating CNS disorders | Aug 20, 19 | Oct 19, 21 | SAGE THERAPEUTICS, INC. |
| 11072630 | Fluorinated and alkylated bile acids | Mar 10, 16 | Jul 27, 21 | Metselex, Inc. |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2025/0099,594 | TARGETED COMPOSITIONS | Sep 12, 24 | Mar 27, 25 | ARBUTUS BIOPHARMA CORPORATION |
| 2025/0011,360 | PREPARATION AND USES OF OBETICHOLIC ACID | Feb 08, 24 | Jan 09, 25 | Not available |
| 2024/0368,213 | COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS | Jun 12, 24 | Nov 07, 24 | Not available |
| 2024/0342,128 | IMMUNE MEMORY INDUCTION BY PLATINUM BASED COMPOUNDS | Jun 24, 24 | Oct 17, 24 | Not available |
| 2024/0342,201 | ASYMMETRIC GPR84 ANTAGONIST AND USE THEREOF | Jul 13, 22 | Oct 17, 24 | Not available |
| 2024/0327,452 | Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use Thereof | Mar 05, 24 | Oct 03, 24 | Not available |
| 2024/0294,567 | FLUORINATED AND ALKYLATED BILE ACIDS | Feb 20, 24 | Sep 05, 24 | Not available |
| 2024/0245,784 | TARGETED NUCLEIC ACID CONJUGATE COMPOSITIONS | Jan 10, 24 | Jul 25, 24 | ARBUTUS BIOPHARMA CORPORATION |
| 2024/0247,026 | SALTS AND CRYSTALLINE FORMS OF (3E) 3-[O-[(PHOSPHONOOXY)METHYL]OXIME]-PREGN-4-ENE-3,20-DIONE AND RELATED USES | Apr 19, 22 | Jul 25, 24 | Not available |
| 2024/0218,013 | Process for the preparation of B-[(7alpha,17beta)-17-hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl) sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]-boronic acid and intermediates of said process | Oct 29, 21 | Jul 04, 24 | Not available |
| 2023/0128,984 | BILE ACID-GCPII INHIBITOR CONJUGATES TO TREAT INFLAMMATORY DISEASES, INCLUDING INFLAMMATORY BOWEL DISEASE (IBD) | Jan 29, 21 | Apr 27, 23 | Not available |
| 2022/0402,965 | STEROL ANALOGS AND USES THEREOF | Sep 19, 19 | Dec 22, 22 | Not available |
| 2022/0106,352 | PROCESS FOR THE PREPARATION OF FULVESTRANT 3-BORONIC ACID | Mar 11, 20 | Apr 07, 22 | FARMABIOS S.P.A. |
| 2021/0188,897 | NEUROACTIVE STEROIDS AND COMPOSITIONS AND METHODS THEREOF | Nov 16, 20 | Jun 24, 21 | Not available |
| 2019/0330,260 | PROCESS | Dec 13, 17 | Oct 31, 19 | Not available |
| 2018/0305,397 | Preparation and Uses of Obeticholic Acid | Apr 30, 18 | Oct 25, 18 | Not available |
| 2018/0002,371 | BUFALIN PHOSPHATE PRODRUGS AND METHODS OF USE THEREOF | Dec 29, 15 | Jan 04, 18 | BAYLOR COLLEGE OF MEDICINE |
| 2017/0022,245 | GANAXOLONE DERIVATIVES FOR TREATMENT OF CENTRAL NERVOUS SYSTEMS DISORDERS | Nov 26, 14 | Jan 26, 17 | BIOPHARMA WORKS |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 34 Months (last 2 years Issuances)
- 34 Months (last 5 years Issuances)